Skip to content

Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes

Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07263945
Acronym
TBAL
Enrollment
60
Registered
2025-12-04
Start date
2025-11-25
Completion date
2030-05-31
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Bone Anchored Devices, Osseointegration, Transtibial Amputation - Unilateral

Keywords

amputation, bone anchored limb, osseointegration, transtibial amputation, below knee amputation, prosthetics

Brief summary

A clinical trial utilizing cross-over study design in which individuals with transtibial amputation using either a bone-anchored limb or standard socket prosthesis will perform activities of daily living with varying prosthetic foot stiffness categories to complete the following 4 Specific Aims: 1) Determine the influence of prosthetic foot stiffness on dynamic bone-implant loading, 2) Determine how prosthetic foot stiffness influences function, pain, and multi-joint biomechanics outcomes, 3) Establish how prosthetic foot stiffness influences osseoperception and fall risk, and 4) Establish target ranges of optimal foot stiffness based on the sensitivity biomechanical outcomes to variability in foot stiffness.

Detailed description

This will be a clinical trial with two groups (individuals with a unilateral transtibial amputation using either an osseointegrated bone-anchored limb or socket prosthesis that will implement a cross-over design. The objective of this clinical trial is to determine how changes in prosthetic foot stiffness influence clinical and biomechanical outcomes in patients with transtibial osseointegrated bone-anchored limbs compared to patients with transtibial amputation using a standard socket-suspended prosthesis. Although proper loading between the bone and implant is pivotal to promote and maintain osseointegration, which is required for physiological loading and thus positive outcomes, evidence surrounding the role of how prosthetic componentry influences force transmission and functional outcomes in this population currently does not exist. The findings of this clinical trial will address a critical knowledge gap pertaining to the role of componentry on multi-loading domain outcomes. Outcomes will be assessed in each participant in the same three conditions: one with their clinical prescribed prosthetic foot, one with a soft prosthetic foot (-2 stiffness categories less than prescribed), and one with a stiff prosthetic foot (+2 stiffness categories more than prescribed). This data will be used to test/develop the following aims: 1) Does foot stiffness change loading between the bone and implant during activities of daily living? 2) Does foot stiffness influence measures of function, pain, and biomechanics in patients with transtibial osseointegrated bone-anchored limbs differently than a socket prosthesis? 3) Does foot stiffness influence sensitivity, balance, and fall risk in patients using an osseointegrated bone-anchored limb different than a socket prosthesis? and 4) (exploratory) develop an optimization platform using computer models to determine the optimal foot stiffness that maximizes joint loading symmetry and minimizes metabolic cost.

Interventions

DEVICEAs-prescribed prosthetic foot stiffness

Each participant will complete a motion capture collection, tests of physical function, and sensory tests in their currently prescribed prosthetic foot.

DEVICEA prosthetic foot that is two prosthetic foot stiffness categories stiffer than the stiffness of the as-prescribed prosthetic foot

Each participant will complete a motion capture collection, tests of physical function, and sensory tests in a prosthetic foot that is two categories stiffer than their currently prescribed prosthetic foot.

DEVICEA prosthetic foot that is two prosthetic foot stiffness categories softer than the stiffness of the as-prescribed prosthetic foot

Each participant will complete a motion capture collection, tests of physical function, and sensory tests in a prosthetic foot that is two categories softer than their currently prescribed prosthetic foot.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Unilateral transtibial amputation due to traumatic, congenital, or cancer-related causes * \> 12-months bone-anchored limb implantation surgery (Bone Anchored Limb group) * \> 12-months limb amputation (Socket Control group) * Non-vascular amputation etiology * Low profile prosthetic foot (nominal) * Can walk unassisted for 5-minutes * \> 18 years old

Exclusion criteria

* Major amputation on contralateral limb * Vascular amputation etiology * Neurologic pathology that impairs coordination/balance * Regular assistive device use required for community ambulation * Inflammatory diseases or diabetes * Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Bone-Implant Stress/Strain Impulse during Decline Walking (internal)Three laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksStress/strain impulse at the bone-implant interface (area under time series curve) will be calculated during the stance period of the decline walk (-5 degrees). Subject-specific finite element models will be developed for each bone-anchored limb participant to calculate this outcome. This will be done by including each participant's movement patterns, muscle forces, joint forces, bone geometry and bone health. Movement patterns, muscle forces, and joint loading will be calculated from musculoskeletal modeling using whole-body motion data collected from 70 wearable reflective markers (Vicon, Centennial, CO), ground reaction forces simultaneously collected from an instrumented treadmill (Bertec, Columbus, OH). Bone geometry and healthy will be determined from quantitative computed tomography bone scans.

Secondary

MeasureTime frameDescription
Bone-Implant Dynamic Stress/Strain Impulse (internal)Three laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksStress/strain impulse at the bone-implant interface (area under time series curve) will be calculated for each bone-anchored limb participant using motion and force data collected during the stance period of treadmill walking at level and incline (+5 degree) angles.
Bone Dynamic Stress/Strain Impulse (internal)Three laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksStress/strain impulse for the amputated tibia bone (area under time series curve) will be calculated for each bone-anchored limb participant using motion and force data collected during the stance period of treadmill walking at level, incline (+5 degree), and decline (-5 degree) angles.
Implant Dynamic Stress/Strain Impulse (internal)Three laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksStress impulse for the prosthesis implant (area under time series curve) will be calculated for each bone-anchored limb participant using motion and force data collected during the stance period of treadmill walking at level, incline (+5 degree), and decline (-5 degree) angles.
Prosthesis Force Impulse (external abutment)Three laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksForce impulse in the vertical direction (area under the time series curve) will be calculated for all study participants using motion and force data collected from the triaxial load sensor in the prosthesis (iPECSTM) during the stance period of treadmill walking at level, incline (+5 degree), and decline (-5 degree) angles.
Sensory ThresholdThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksWith each foot (stiff, nominal (as-prescribed), soft), participants will stand on a platform with the prosthetic equivalent of the head of the third metatarsal in contact with an extension pin delivering a vibration. While wearing noise-reducing headphones, three different vibration frequencies will be tested in a randomized order: 8, 32, and 125 Hz. At each frequency, custom software will increase and decrease the vibrational amplitude at a rate of 0.2 dB/s. Using an integrated push button, the participant will indicate when sensation is felt (during increasing amplitude) or when sensation is lost (during decreasing amplitude), which will be the sensory threshold.
Postural SwayThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksPostural sway will be quantified during quiet standing with eyes open and eyes closed condition. Using the center of pressure measured from the force platform under both feet, path length and 95% confidence ellipse area will be calculated.
Reactive Postural Control TimeThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksReaction times during stepping responses to rapid treadmill belt perturbations will be measured using a force-instrumented treadmill (Bertec, Columbus, OH, USA).
Whole-Body Angular MomentumThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksPeak-to-peak whole-body angular momentum will be calculated as a measure of dynamic balance during each dynamic functional activity (level/incline/decline walking and stair ascent/descent) and treadmill perturbation.
Self-Selected Gait SpeedThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksGait velocity will be calculated using the time it takes each participant to walk 5-meters at their preferred, self-selected pace, averaged over three trials.
L-Test TimeThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksThe L-test will be quantified as the time it takes to stand up from a chair, walk 3-meters, complete a 90° left turn, walk 7-meters, completed a 180° turn, walk back on the same path, turn, and sit down.
Acceptability of Intervention MeasureThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksThe Acceptability of Intervention Measure is a 4-item, Likert-scale (5 point) self-report questionnaire assessing participant acceptability of the intervention (prosthetic foot type). Final scores range from 1 to 5 points, as the mean of the four items, with higher scores indicating greater acceptability.
Prosthetic Limb Users Survey of MobilityThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksThe Prosthetic Limb Users Survey of Mobility is a 12-item, Likert scale (5 point) self-report questionnaire assessing participant mobility when using a prosthesis. Final scores range from 12 to 60 points with higher scores indicating greater mobility.
Activities-Specific Balance Confidence ScaleThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksThe Activities-Specific Balance Confidence Scale is a 16-item, 0-100 scale, self-reported questionnaire assessing participant balance confidence. Final scores range from 0% (no confidence in balance) to 100% (complete confidence in balance).
Joint Reaction ForceThree laboratory visits, each lasting approximately 4 hours, spanning across approximately 6-8 weeksBilateral hip and knee joint reaction forces (normalized to body weight) will be calculated during treadmill walking using a combination of motion-capture data and subject-specific musculoskeletal models.

Countries

United States

Contacts

CONTACTBrecca Gaffney, PhD
BRECCA.GAFFNEY@UCDENVER.EDU303-315-7559
CONTACTNatalie Harpenau, MS
NATALIE.HARPENAU@CUANSCHUTZ.EDU‪(720) 772-6887

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026